AbramsP. H., ChoaR. G., CachesC. G. C., AskenM. H., GreenN. A.: A controlled trial of single dose intravesical adriamycin in superficial bladder tumors. Brit. J. Urol., 53; 585 (1981).
2.
BanksM. D., PontesJ. E., IzbiickiR. M., PierceJ. M.Jr.: Topical instillation of Doxorubicin hydrocloride in the treatment of recurring superficial transitional cell carcinoma of the bladder. J. Urol., 118; 757–760 (1977).
3.
HornJ., EidelmanA., WalachN., IlianM.: Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride. J. Urol., 125; 652–6541981).
4.
IngargiolaG. B., LamartinaM., Pavone MacalusoM., TripiM., Gruppo Urologico dell'EORTC Sezione Italiana: Protocolli di chemioprofilassi endovescicale dell'EORTC. Risultati preliminari degli studi in corso (30782 e 30790). Atti Soc. Ital. Urol., 55° Congr., p. 57–61. Catania 1982.
5.
LibertiM., De BernardisE., TenagliaR., VerriA., TacciuoliM.: Consideration on the results obtained by intravesical therapy with Adriamycin and Mitomycin C in 102 patients who underwent T.U.R. for superficial bladder tumors Pt1 (G1- G3): comparison between the two drugs. Advances in Urological Oncology and Endocrinology, Acta Medica Ed., 369–375 (1984).
6.
SoloweyM. S.: Rationale for intensive intravesical chemoterapy for superficial bladder cancer. J. Urol., 123; 461–466 (1980).
7.
SmithM. D., DonaldR.: General Urology.11 Ed., p. 330–335 (1984).
ZinckeH., HutzD. C., TaylorW. F., MyersR. P., LearyF. J.: Influence of Thiotepa and Doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized double blind, control trial. J. Urol., 129; 505–509 (1983).
